Background: Urocortin 1 (UCN1) has cardiostimulatory, vasodilatory, diuretic and natriuretic effects, and its expression increases in heart failure (HF).
With
-
-
General HealthHealth
Heart failure in covid-19: the multicentre, multinational pchf-covicav registry
by clinicby clinicAims: We assessed the outcome of hospitalized coronavirus disease 2019 (COVID-19) patients with heart failure (HF) compared with patients with other cardiovascular disease and/or risk factors (arterial hypertension, diabetes, or dyslipidaemia). We further wanted to determine the incidence of HF events and its consequences in these patient populations.
Share this:
-
General HealthHealth
Real-life multicenter survey evaluating stroke prevention strategies in non-valvular atrial fibrillation (ramses study)
by clinicby clinicThe RAMSES study showed a higher prevalence of OAC use among NVAF patients than that reported in previous studies. Although NOACs were preferred over VKAs in daily cardiology practice, there is a need for improved OAC therapies for NVAF patients.
Share this:
-
General HealthHealth
Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in turkey
by clinicby clinicA total of 1098 patients (male, 47.5%; mean age, 83.5±3.1 years) aged ≥80 years and 4596 patients (male, 50.2 %; mean age, 71.1±4.31 years) aged 65-79 years were enrolled in this study . The prevalence of HF was 39.8% for patients who were ≥80 years and 27.1% for patients 65–79 years old. For patients aged ≥80 years with HF, the prevalence rate was 67% for hypertension (HT), 25.6% for diabetes mellitus (DM), 54.3% for coronary artery disease (CAD), and 42.3% for atrial fibrillation. Female proportion was lower in the HFrEF group (p=0.019). The prevalence of HT and DM was higher in the HFpEF group (p<0.01), whereas CAD had a higher prevalence in the HFrEF group (p=0.02). Among patients aged 65–79 years, 43.9% (548) had HFpEF, and 56.1% (700) had HFrEF. In this group of patients aged 65-79 years with HFrEF, the prevalence of DM was significantly higher than in patients aged ≥80 years with HFrEF (p<0.01). Conclusion: HF is common in elderly Turkish population, and its frequency increase
Share this:
-
General HealthHealth
Clinical investigations qt dispersion ratio in patients with unstable angina pectoris (a new risk factor?) vg cin, md,m. cei.jk, md, p. ulucan,md selquk university, school of medicine, cardiac department, konya, turkey
by clinicby clinicSummary Background: QT dispersion has been shown to be associated with fatal arrhythmias and sudden death in coronary artery disease. A recent study indicated that marked QT dispersion in electrocardiograms (ECGs) obtained during acute ischemia demonstrated a significant correlation with ventricular tibrillation. Hypothesis: This study investigated the ECG parameters for repolarization (QT dispersion, corrected QT, corrected QT dispersion, and QT dispersion ratio) and their interrelation with acute ischemia. Merh0d.s: QT parameters as well as a newly developed repolarization index, QT dispersion ratio [(QT dispersion/RR interva1)X 1001 were calculated digitally during rest and ischemia in 32 patients with coronary artery disease (rest angina, Braunwald class III) . Results were correlated with clinical consequences, mainly arrhythmias, within a follow-up period of 5 k 2 days. RPSM~LSS: While most patients had an increase in all four parameters, only the QT dispersion ratio s
Share this:
-
General HealthHealth
Effects of ivabradine on 6-minute walk test and quality of life in patients with previously implanted crt-d
by clinicby clinicIvabradine treatment produced dose-dependent reductions in heart rate at rest and at peak exercise (91.9 ± 6.3 to 71.7 ± 4.8 and 114.4 ± 7.6 to 96.8 ± 4.8; P = 0.001 and P = 0.001, respectively). There were also significant improvements in life quality score (52.4 ± 9.5 to 37.9±7.8; P = 0.001) and 6-minute walking distance (278.7 ± 85.8 to 373.3 ± 94.0; P = 0.001) of patients. All patients with New York Heart Association class III became class II after 3 months of ivabradine treatment.
Share this:
-
General HealthHealth
New technique for challenging cases of percutaneous balloon mitral valvuloplasty: the venoarterial looping
by clinicby clinicMitral stenosis (MS) is generally the sequel of rheumatic carditis occurring in childhood (1). MS is particularly observed in developing countries (1, 2). Untreated patients can develop irreversible right ventricular failure (1, 2). Since its introduction by Inoue, percutaneous mitral balloon valvuloplasty (PMBV) is considered the leading and effective treatment option for symptomatic moderate to severe MS with favorable valve morphology (3, 4). PMBV provides immediate and sustained hemodynamic improvement, comparable with the results of surgery (3). However, there are challenges in some cases of PMBV, where surgery is also not feasible. Various techniques have been described for directing the mitral balloon catheter to left ventricle during PMBV (5-9). Here we aim to define a new technique for challenging cases of PMBV in patients with a large left atrium and a severe MS called the venoarterial looping.
Share this:
-
General HealthHealth
Peripheral artery disease and atrial fibrillation: the dangerous combination
by clinicby clinicPeripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination Ahmet Keser, Kerem Özbek, Hüseyin Katlandur, Şeref Ulucan PMID: 27386782 DOI: 10.1016/j.jacc.2016.03.594 Free article
Share this:
-
General HealthHealth
Deterioration of heart rate recovery index in patients with erectile dysfunction
by clinicby clinicAll HHR indices were found to be significantly decreased in patients with erectile dysfunction (p<0.001). Effort capacity was markedly lower (9.1±2.3 vs. 10.4±2.3 METs, p=0.002) among patients with erectile dysfunction. HRR1 and HRR3 were found to be an independent risk factor for erectile dysfunction (Beta=0.462, p<0.001; Beta=0.403, p<0.001; respectively) in linear regression analysis.
Share this:
-
General HealthHealth
Outcomes of transradial primary percutaneous intervention from a tertiary cardiac center in turkey
by clinicby clinicObjectives: The aim was to study transradial approach (TRA) and transfemoral approach (TFA) in terms of feasibility, effectiveness, usefulness, and procedure characteristics in patients having ST-segment elevation myocardial infarction (STEMI) and undergoing primary percutaneous coronary intervention (PCI) ). Along with the said aim, major adverse cardiovascular events (MACE) at follow-ups were also compared. Methods: The present study was conducted on 344 consecutive patients having ST-segment elevation myocardial infarction and qualifying for PCI. Patients were classified into two groups according to radial and femoral approaches. Patients were followed-up for MACE. Results: PCI was found to be successful in all patients. In TRA group the time between the end of the intervention to removal of the sheath, and duration of mobilization and hospitalization were significantly shorter when compared to TFA group (12 ± 2 minutes vs. 240 ± 12 minutes; P = 0.001, 13 ± 2 hours vs. 22 ± 2 hours;
Share this:
